Current situation of EGPA in Japan

Synopsis:

Information coming soon

Food inclusions:

TBA

Agenda:


	Chairperson: Prof. Shingo Nakayamada
TBA mins	Improving patient outcomes and changing the landscape in EGPA treatment – Lessons learned with Mepolizumab A/Prof. Tomohiro Koga
TBA mins	Closing Remarks: Q&A and Discussion All

Key dates

About

Partnership / Exhibition

Program

Follow

Stay updated with APLAR Congress, and other related events.

From key date reminders, abstract closures, program release updates, and speaker announcements, the best place to stay across APLAR Congress information is with the official congress mailing list.

You can opt out at anytime.

If you are translating this website, phrase based translation is used and may not be completely accurate.

Designed and built by MCI Australia